{"id":14790,"date":"2012-04-18T01:30:00","date_gmt":"2012-04-17T23:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/jama-ancora-debole-la-ricerca-comparativa\/"},"modified":"2012-04-18T01:30:00","modified_gmt":"2012-04-17T23:30:00","slug":"jama-ancora-debole-la-ricerca-comparativa","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/jama-ancora-debole-la-ricerca-comparativa\/","title":{"rendered":"Jama, comparative research still weak"},"content":{"rendered":"<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: BookAntiqua; color: #212120; mso-bidi-font-family: BookAntiqua\"><font size=\"3\"><font face=\"Calibri\">It is necessary to involve more patients, but also clinicians and other operators, in the development of comparative research on the efficacy of drugs. A step forward in this direction will prove very useful when deciding on a therapy. This was underlined by the researchers of the Patient-Centered Outcomes Research Institute USA, in an article-appeal published in &#039;Jama&#039;. Researchers point to the weakness of research in this area. The institute itself was created to fund and promote comparative efficacy studies, &quot;crucial for providing key information to doctors, patients and decision makers&quot;, explain the authors. <\/p>\n<p><\/font><\/font><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><font face=\"Calibri\"><span style=\"font-family: BookAntiqua; color: #212120; mso-bidi-font-family: BookAntiqua\"><font size=\"3\">The center has taken action, putting in place ad hoc protocols and tenders. The idea is that &quot;greater involvement of patients, physicians and other scientists in the research process of this type could help reorient clinical research itself, reducing uncertainty and accelerating the speed in the adoption of meaningful and promising results<\/font><\/span><span style=\"font-family: BookAntiqua; color: #212120; font-size: 9pt; mso-bidi-font-family: BookAntiqua\">&quot;.<\/p>\n<p><\/span><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><em><span style=\"line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; color: #212120; font-size: 9pt; mso-bidi-font-weight: bold\">April 18, 2012 \u2013 Margherita Lopes \u2013 PharmaKronos<\/span><\/em><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><span style=\"line-height: 115%; font-size: 9pt\"><\/p>\n<p><img","protected":false},"excerpt":{"rendered":"<p>Occorre coinvolgere pi&ugrave; pazienti, ma anche clinici e altri operatori, nello sviluppo di ricerche di tipo comparativo sull&#8217;efficacia dei farmaci. Un passo avanti in questa direzione si riveler&agrave; molto utile al momento di decidere una terapia. Lo sottolineano i ricercatori del Patient-Centered Outcomes Research Institute Usa, in un articolo-appello pubblicato su &#8216;Jama&#8217;. I ricercatori puntano &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14790","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14790"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14790\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14790"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14790"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}